Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$482.27 USD

482.27
956,306

-6.51 (-1.33%)

Updated Oct 3, 2024 04:00 PM ET

Pre-Market: $481.53 -0.74 (-0.15%) 9:12 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (168 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Intuitive Surgical (ISRG) Falls Following Q4 Earnings Miss

by Zacks Equity Research

Intuitive Surgical's (ISRG) fourth-quarter results reflect healthy demand for procedures, partially offset by lower system sales and unfavorable currency. Procedure volume in China suffers.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

by Zacks Equity Research

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

McKesson (MCK) Gains As Market Dips: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed at $376.50 in the latest trading session, marking a +0.39% move from the prior day.

Quest Diagnostics (DGX) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

Quest Diagnostics (DGX) ramps up investments to accelerate growth in the base business, particularly in advanced diagnostics and direct-to-consumer testing.

Stryker (SYK) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

Stryker's (SYK) fourth-quarter results are likely to reflect its strong segmental performances. However, rising costs are likely to have continued to have hurt margins during the quarter.

IDEXX (IDXX) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

IDEXX's (IDXX) CAG premium instrument placements are expected to have recorded significant growth in Q4 owing to continued rise in Catalyst and premium hematology placements.

Non-COVID Diagnostics Sales to Aid Hologic (HOLX) Q1 Earnings

by Zacks Equity Research

The growing adoption of Panther instruments worldwide will likely drive Hologic's (HOLX) Q1 revenues.

Intuitive Surgical (ISRG) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Intuitive Surgical's (ISRG) fourth-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock Now

by Zacks Equity Research

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

McKesson (MCK) Stock Moves -1.32%: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $378.40, moving -1.32% from the previous trading session.

Align Technology (ALGN) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Align Technology's (ALGN) increased shipments in Invisalign case volumes across almost all markets are likely to benefit Q4 revenues.

Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Merit Medical (MMSI), owing to its strong product portfolio.

Here's Why You Should Retain Intuitive Surgical (ISRG) Stock

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to gain traction from the increasing adoption of the da Vinci Surgical System. Improving margins buoy optimism.

Hologic (HOLX) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Growing adoption of Panther instruments and growth in the Surgical business will likely drive Hologic's (HOLX) Q1 revenues.

Is Laboratory Corp. of America (LH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Reasons to Retain West Pharmaceutical (WST) in Your Portfolio

by Zacks Equity Research

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for CLRG

Zacks.com featured highlights DCP Midstream Partners, Herc Holdings, MRC Global and McKesson

by Zacks Equity Research

DCP Midstream Partners, Herc Holdings, MRC Global and McKesson have been highlighted in this Screen of The Week article.

Vasundhara Sawalka headshot

4 Stocks Trading Near 52-Week High That Can Scale Higher

by Vasundhara Sawalka

Investors target stocks that have been on a bullish run lately. Stocks like HRI, DCP, MRC and MCK that are seeing price strength have a high chance of carrying the momentum forward.

McKesson (MCK) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed at $381.96 in the latest trading session, marking a -1.06% move from the prior day.

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how McKesson (MCK) and Doctor Reddy's (RDY) have performed compared to their sector so far this year.

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for CLRG

McKesson (MCK) Flat As Market Sinks: What You Should Know

by Zacks Equity Research

In the latest trading session, McKesson (MCK) closed at $375.12, marking no change from the previous day.